Aerosolised antibiotics for the management of healthcare-associated pneumonia (HCAP) and ventilator-associated pneumonia (VAP)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the benefits and harms of aerosolised antibiotics, comparing aerosolised versus systemic antibiotics, aerosolised antibiotics versus placebo and the addition of aerosolised to systemic antibiotics versus systemic antibiotics alone.